News
Pheno and USB reveal neurodegenerative disease programme agreement
Pheno Therapeutics (Pheno)– a company focused on the development of small molecule therapeutics for the treatment of neurological diseases – has announced that it has entered into an exclusive worldwide licence agreement with UCB.